title: Novel approaches to assessing cardiac safety--proceedings of a workshop: regulators, industry and academia discuss the future of in silico cardiac modelling to predict the proarrhythmic safety of drugs.
authors.affiliation: University of Oxford, Oxford, UK. katherine.fletcher@dpag.ox.ac.uk
authors.forename: Katherine
authors.initials: K
authors.lastname: Fletcher
authors.forename: Rashmi R
authors.initials: RR
authors.lastname: Shah
authors.forename: Arthur
authors.initials: A
authors.lastname: Thomas
authors.forename: Frank
authors.initials: F
authors.lastname: Tobin
authors.forename: Blanca
authors.initials: B
authors.lastname: Rodriguez
authors.forename: Gary R
authors.initials: GR
authors.lastname: Mirams
authors.forename: Javier
authors.initials: J
authors.lastname: Saiz
authors.forename: Denis
authors.initials: D
authors.lastname: Noble
mesh_terms: D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D003198:Computer Simulation; D015195:Drug Design; D064420:Drug-Related Side Effects and Adverse Reactions; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels / Q000037:antagonists & inhibitors; D005544:Forecasting; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced
chemical_list: D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels